Resveratrol induces p53 and suppresses myocardin-mediated vascular smooth muscle cell differentiation.
Resveratrol (RSVL), a polyphenolic antioxidant present in red wine, has been shown to provide cardiovascular protection by improving endothelial function and reducing myocardial ischemia. However, little is known about how RSVL affects vascular smooth muscle cells (VSMCs) differentiation. RSVL blocks VSMC proliferation in vitro and neointimal formation following artery injury in vivo. Thus, one might expect that RSVL will promote VSMC differentiation. Unexpectedly, our results in this study show that RSVL induces VSMCs phenotypic modulation; this is characterized by suppressed transcription of SMC-specific marker genes Tagln, Acta2, Myh11, and Smtn in a dose-dependent and time-dependent manner in cultured VSMCs. Consistent with previous studies, RSVL induces the nuclear translocation of p53 and the expression of p53-responsive genes such as Cdkn1a, Gadd45a, Gadd45, and Fas. In an effort to identify the molecular mechanisms whereby RSVL represses VSMC differentiation, we found that RSVL inhibits the transcription of Myocardin (myocd) and Srf, the key VSMC transcriptional regulators. However, knockingdown and overexpressing p53 did not affect RSVL-induced VSMCs phenotypic modulation: this suggests that RSVL may induce VSMC dedifferentiation via p53-independent mechanisms. This study provides the first evidence showing that RSVL induces VSMC dedifferentiation by regulating Myocardin and SRF-mediated VSMC gene transcription.
Zheng
Jian-Pu
JP
Department of Internal Medicine, Wayne State University, Detroit, MI 48201, USA.
Ju
Donghong
D
Jiang
Hong
H
Shen
Jianbin
J
Yang
Maozhou
M
Li
Li
L
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects*; D032389:Myocytes, Smooth Muscle / Q000166:cytology / Q000187:drug effects*; D009687:Nuclear Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D051381:Rats; D000077185:Resveratrol; D026362:Serum Response Factor / Q000037:antagonists & inhibitors / Q000235:genetics; D015398:Signal Transduction / Q000187:drug effects; D013267:Stilbenes / Q000494:pharmacology*; D015534:Trans-Activators / Q000037:antagonists & inhibitors* / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000502:physiology*; D000099251:Myocardin
D009687:Nuclear Proteins; D000077185:Resveratrol; D026362:Serum Response Factor; D013267:Stilbenes; D015534:Trans-Activators; D016159:Tumor Suppressor Protein p53; D000099251:Myocardin
Arch Med Res. 2008 Feb;39(2):155-61
18164958
Biochem Biophys Res Commun. 2003 Nov 14;311(2):546-52
14592451
PLoS One. 2008;3(11):e3707
19002260
Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1263-9
18420994
Circulation. 2002 Sep 24;106(13):1652-8
12270858
Circ Res. 2003 May 2;92(8):856-64
12663482
Biochem Pharmacol. 2004 Feb 15;67(4):777-85
14757178
J Immunol. 2000 Jun 15;164(12):6509-19
10843709
J Clin Invest. 1994 Jun;93(6):2393-402
8200973
Exp Mol Pathol. 2010 Feb;88(1):52-7
19874818
Circ Res. 2007 Mar 16;100(5):607-21
17363707
Nature. 2003 Sep 11;425(6954):191-6
12939617
Recent Pat Cardiovasc Drug Discov. 2007 Jun;2(2):133-8
18221111
Circ Res. 2004 Apr 16;94(7):863-5
15044321
Biochem Biophys Res Commun. 2006 Jul 21;346(1):367-76
16759640
Development. 2006 Nov;133(21):4245-56
17021041
Cell. 2001 Jun 29;105(7):851-62
11439182
Eur J Pharmacol. 2005 May 16;515(1-3):1-9
15878161
Toxicol Sci. 2004 Dec;82(2):614-9
15329443
J Nutr. 2005 Dec;135(12):2767-73
16317118
Dev Biol. 1997 Jul 15;187(2):311-21
9242426
Cardiovasc Res. 2010 Feb 1;85(3):514-9
19815564
Arch Biochem Biophys. 2009 Jun 15;486(2):95-102
19514131
Circulation. 1992 Dec;86(6):1977-86
1333373
Dev Cell. 2010 Apr 20;18(4):510-25
20412767
J Cell Biol. 1996 Mar;132(5):849-59
8603917
BMC Genomics. 2007 Jul 16;8:237
17634102
Am J Physiol Cell Physiol. 2007 Jan;292(1):C70-81
16928770
J Vasc Res. 2010;47(2):168-80
19851078
Exp Cell Res. 2009 Oct 15;315(17):2953-62
19665018
J Pharmacol Exp Ther. 2010 Apr;333(1):34-42
20089806
Circ Res. 2010 Apr 30;106(8):1351-62
20224039
J Vasc Surg. 2005 Dec;42(6):1190-7
16376213
Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H1027-37
19168719
Arterioscler Thromb Vasc Biol. 2009 Aug;29(8):1164-71
19478208
Curr Opin Genet Dev. 2004 Oct;14(5):558-66
15380248
Thromb Res. 2002 Aug 15;107(3-4):141-5
12431480
J Biol Chem. 2005 Mar 11;280(10):9719-27
15623517
Lancet. 1993 Feb 20;341(8843):454-7
8094487
Circ Res. 2005 Feb 18;96(3):280-91
15718508
Biochem Biophys Res Commun. 2000 Jul 21;274(1):61-7
10903896
J Clin Invest. 2000 Nov;106(9):1139-47
11067866
J Intern Med. 2006 Sep;260(3):192-210
16918817
J Thorac Cardiovasc Surg. 2009 Dec;138(6):1392-9
19931668
Biochem Pharmacol. 2001 Oct 15;62(8):1113-24
11597580
Biochem Pharmacol. 2000 Apr 1;59(7):865-70
10718345
Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H859-66
18065527